Natural killer cells and metastases from pharyngeal carcinoma

Mickel, 1988, Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients, Cancer Res, 48, 5017 Schantz, 1987, Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer, Cancer Immunol Immunother, 25, 141, 10.1007/BF00199955 Schantz, 1988, Natural killer cell activity predicts metastases from poorly-differentiated head and neck cancer (abstr), 29, 374 Grossman, 1986, Natural killer cells and their relationship to T-cells: hypothesis on the role of T-cell receptor gene rearrangement on the course of adaptive differentiation, Cancer Res, 46, 2651 Lanier, 1986, The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes, J Immunol, 136, 4480 Phillips, 1987, In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy, J Clin Oncol, 5, 1933, 10.1200/JCO.1987.5.12.1933 McMannis, 1988, In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2, J Immunol, 140, 1335 Schantz, 1986, Pharyngeal carcinoma and natural killer cell activity, Am J Surg, 152, 467, 10.1016/0002-9610(86)90326-0 Maxim, 1978, Soluble immune complexes in sera from head and neck cancer patients: a preliminary report, Otolaryngology, 86, 428, 10.1177/019459987808600310 Denaro, 1985, Circulating immunocomplexes and laryngeal carcinoma, Arch Otolaryngol, 111, 595, 10.1001/archotol.1985.00800110073005 Pedersen, 1986, Inhibition of natural killer cell activity by antigen-antibody complexes, Allergy, 41, 568, 10.1111/j.1398-9995.1986.tb00348.x Karsh, 1981, Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus, Clin Immunol Immunopathol, 19, 437, 10.1016/0090-1229(81)90086-6 1983, 25 Sacks, 1988, Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck, Cancer Res, 48, 2858 Schantz, 1988, Association of levels of circulating Clq binding macromolecules with induction chemotherapy response in head and neck cancer patients, Cancer Res, 48, 5868 Storrs, 1983, Clq binding and C1 activation by various isolated cellular membranes, J Immunol, 131, 416 Grimm, 1982, Lymphokine-activated killer cell phenomenon: lysis of natural killerresistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes, J Exp Med, 155, 1823, 10.1084/jem.155.6.1823 Itoh, 1985, Leu-11 + lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin-2 (IL-2) induced activated killer (AK) cells, J Immunol, 134, 802 Rosenberg, 1987, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone, N Engl J Med, 316, 889, 10.1056/NEJM198704093161501